Thoracic involvement in Hodgkin's lymphoma;Atteintes thoraciques au cours des lymphomes Hodgkiniens

Revue des Maladies Respiratoires

Volumn 24, Issue 8, 2007, Pages 999-1012

  Cracco, C ^a   Divine, M ^b   Maitre, B ^a,b  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

Bleomycin; Disease; Hodgkin's lymphoma; Lung; Radiotherapy; Sarco dosis

Indexed keywords

BLEOMYCIN; FLUORODEOXYGLUCOSE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ARTICLE; BACTERIAL INFECTION; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER RISK; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; GRANULOMATOSIS; GRANULOMATOUS INFLAMMATION; HISTOCHEMISTRY; HODGKIN DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; INFECTION; LUNG CARCINOGENESIS; LUNG PARENCHYMA; MOLECULAR BIOLOGY; PNEUMOTHORAX; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RESPIRATORY TRACT INFECTION; SOLID TUMOR; THORACIC CAVITY; VIRUS INFECTION;

EID: 36248971818     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0761-8425(07)92764-3     Document Type: Article

References (73)

1. Fraser RG, ParéJAP, ParéPD, Fraser RS, Genereux GP: Hodkin's disease in Lymphoreticular neoplasms and leukemia Diagnosis of diseases of the chest, troisième édition, 1507-685.
2. Canadian Cancer Statistics 2004. Canadian Cancer Society, National Cancer Institute of Canada, Statistics Canada, provincial/territorial Cancer Registries, Health Canada. www.cancer.ca
3. Bureau of Census: Manual of the international list of causes of death, fourth edition 1939. Washington DC, US Government printing office, 1940.
4. Küppers R, Rajewsky K, Zhao M, Simons G, Laumann R, Fisher R, Hansmann ML: Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. PNAS USA 1994;91:10962-6.
5. Re D, Thomas RK, Behringer K, Dielh V: From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential. Blood 2005;105:4553-60.
6. Poppema S: Hodgkin lymphoma: Immunobiology and pathophysiology of Hodgkin lymphomas. Hematology (American Society of Hematology Educational Program) 2005:231-8.
7. Meyer RM, Ambinder RF, Stroobants S: Hodgkin's lymphoma: evolving concepts with implications for practice. Hematology (American Society of Hematology Educational Program), 2004:184-202.
8. Jaffe ES, Harris NZ, Diebold J, Muller-Hermelink HK: World Health Organization classification of lymphomas: a work in progress. Annals of Oncology 1998;S5:S25-30.
9. Connors JM: State-of-the-art therapeutics: Hodgkin's lymphoma. J Clin Oncol 2005, 23:6400-8.
10. Santoro A, Bonfante V, Bonadonna G: Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease. Ann Intern Med 1982;96:139-43.
11. Diehl V, Sieber M, Ruffer U, Lathan B, Hasenclever D, Pfreundschuh M, Loeffler M, Lieberz D, Koch P, Adler M, Tesch H: BEA-COPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. The German Hodgkin's Lymphoma Study Group. Ann Oncol 1997;8:143-8.
12. Colby TV, Hoppe RT, Warnke RA: Hodgkin's disease: clinico-pathologic study of 659 cases. Cancer 1981;49:1848-58.
13. Rostock RA: New aspects of Hodgkin's disease: staging for conservative management. Critical Review of Oncology and Hematology 1984;1:295-321.
14. Liew KH, Easton D, Horwich A, Barrett A, Peckham MJ: Bulky mediastinal Hodgkin's disease management and prognosis. Hematol and Oncol 1984;2:45-59.
15. Constans M, Sureda A, Terol MJ, Arranz R, Caballero MD, Iriondo A, Jarque I, Carreras E, Moraleda JM, Carrera D, Leon A, Lopez A, Albo C, Diaz-Mediavilla J, Fernandez-Abellan P, Garcia-Ruiz JC, Hernandez-Navarro F, Mataix R, Petit J, Pascual MJ, Rifon J, Garcia-Conde J, Fernandez-Ranada JM, Mateos MV, Sierra J, Conde E; GEL/TAMO Cooperative Group: Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcome. Ann Oncol 2003;14:745-51.
16. Glimelius I, Molin D, Amini RM, Gustavsson A, Glimelius B, Emblad G: Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB. Eur J Haematol 2003;71:327-33.
17. Sureda A, Constans M, Iriondo A, Arranz R, Caballero MD, Vidal MJ, Petit J, Lopez A, Lahuerta JJ, Carreras E, Garcia-Conde J, Garcia-Larana J, Cabrera R, Jarque I, Carreras D, Garcia-Ruiz C, Pascual MJ, Rifon J, Moraleda JM, Perez-Equuiza K, Albo C, Diaz-Mediavilla J, Torres A, Torres P, Besalduch J, Mateos MV, Fernandez-Ranada JM, Sierra J, Conde E pour le Grupo Espanol de Limfomas/Trasplante autologo de Medula Osea Cooperative Group: Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse. Ann Oncol 2005;16:625-33.
18. Castellino RA, Blank N, Hoppe RT, Cho C: Hodgkin disease: contributions of chest CT in the initial staging evaluation. Radiology 1986;160:603-5.
19. Hopper KD, Diehl LF, Lesar M, Barnes M, Granger E, Baumann J: Hodgkin disease: clinical utility of CT in initial staging and treatment. Radiology 1988;169:17-22.
20. Diehl LF, Hopper KD, Giguere J, Granger E, Lesar M: The pattern of intrathoracic Hodgkin's disease assessed by computed tomography. J Clin Oncol 1991;9:438-43.
21. Diederich S, Link TM, Zühlsdorf H, Steinmeyer E, Wormanns D, Heindel W: Pulmonary manifestations of Hodgkin's disease: radiographic and CT findings. Eur Radiol 2001;11:2295-305.
22. Bishop PC, Elwood PC: Images in clinical medicine: chylous effusion in Hodgkin's disease. N Engl J Med 1998;339:1515.
23. Jeffery GM, Mead GM, Whitehouse JM: Life-threatening airway obstruction at the presentation of Hodgkin's disease. Cancer 1991;67:506-10.
24. Yousem SA, Weiss LM, Colby TV: Primary pulmonary Hodgkin's disease. Cancer 1986;57:1217-24.
25. Radin RI: Primary pulmonary Hodgkin's disease. Cancer 1990;65:550-63.
26. Cartier Y, Johkoh T, Honda O, Müller NL: Primary pulmonary Hodgkin's disease: CT findings in three patients. Clin Radiol 1999;54:182-4.
27. Costa MB, Siqueira SA, Saldiva PH, Rabe KF, Mauad T: Histologic patterns of lung infiltration of B-cell, T-cell, and Hodgkin lymphomas. Am J Clin Pathol 2004;121:718-26.
28. Frija J: Lymphomes et dysglobulinémies in Imagerie thoracique de l'adulte par Grenier P, 1e édition Médecine-Sciences, Flammarion, 1996;269-81.
29. Patsouris E, Noel H, Lennert K: Cytohistologic and immunohistochemical findings in Hodgkin's disease, mixed cellularity type, with a high content of epithelioid cells. Am J Surg Pathol 1989;13:1014322.
30. Naumann R, Beuthien-Baumann B, Reiss A, Schulze J, Hanel A, Bredow J, Kuhnel G, Kropp J, Hanel M, Laniado M, Kotzerke J, Ehninger G: Substancial impact of FDG PET imaging on the therapy decision in patient with early-stage Hodgkin's lymphoma. Brit J Cancer 2004;90:620-5.
31. Loyer E, Fuller L, Libshitz HI, Palmer JL: Radiographic appearance of the chest following therapy for Hodgkin disease. Eur J Radiol 2000;35:136-48.
32. Notter DT, Grossman PL, Rosenberg SA, Remington JS: Infections in patients with Hodgkin's disease: a clinical study of 300 consecutive adult patients. Rev Infectious Dis 1980;2:761-800.
33. Foss Abrahamsen A, Hoiby EA, Hannisdal E, Jorgensen OG, Holte H, Hasseltvedt V, Host H: Systemic pneumococccal disease after staging splenectomy for Hodgkin's disease 1969-1980 without pneumococcal vaccine protection: a follow-up study 1994. Eur J Haematol 1997;58:73-7.
34. Pagano L, Fianchi L, Mele L, Girmenia C, Offidani M, Ricci P, Mitra ME, Caramatti C, Piccaluga P, Nosari A, Buelli M, Allione B, Cortelezzi A, Fabbiano F, Milone G, Invernizzi R, Martino B, Masini L, Todeschini G, Cappucci MA, Russo D, Corvatta L, Martino P, Del Favero A: Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres. Brit J Haematol 2002;117:379-86.
35. Catterall JR, McCabe RE, Brooks RG, Remington JS: Open lung biopsy in patients with Hodgkin's disease and pulmonary infiltrates. Am Rev Respir Dis 1989;139:1274-9.
36. Singer C, Armstrong D, Rosen PP, Schottenfeld D: Pneumocystis carinii pneumonia: a cluster of eleven cases. Ann Intern Med 1975;82:772-7.
37. Jayshree RS, Appaji L, Sridhar H: Pneumocystis carinii pneumonia in two patients with Hodgkin's disease. Ind J Cancer 1995;32:74-6.
38. Bondoc AYP, White DA: Granulomatous Pneumocystis carinii pneumonia in patients with malignancy. Thorax 2002;57:435-7.
39. Hirsch A, Vander Els N, Straus DJ, Gomez EG, Leung D, Portlock C, Yahalom J: Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin's disease. J Clin Oncol 1996;14:1297-305.
40. Villani F, De Maria P, Bonfante V, Viviani S, Laffranchi A, dell'oca I, Diruso A, Zanini M: Late pulmonary toxicity after treatment for Hodgkin's disease. Anticancer Res 1997;17:4739-42.
41. Horning SJ, Adhikari A, Rizk N, Hoppe RT, Olshen RA: Effect of treatment for Hodgkin's disease on pulmonary function: result of a prospective study. J Clin Oncol 1994;12:297-305.
42. Villani F, Dell'oca, De Maria P, Viola G, Di Russo A, Viviani S, Bonfante V: Lung function and serum concentration of tumor necrosis facto-alpha, interleukin-6 and fibronectin in patients treated with ABVD chemotherapy followed by radiotherapy for mediastinal Hodgkin's disease. Anticancer Res 1999;19:4475-9.
43. Salloum E, Tanoue LT, Wackers FJ, Zelterman D, Hu GL, Cooper DL: Assessment of cardiac and pulmonary function in adult patients with Hodgkin's disease treated with ABVD or MOPP/ABVD plus adjuvant low-dose mediastinal irradiation. Cancer Inv 1999;17:171-80.
44. Stromberg JS, Sharpe MB, Kim LH, Kini VR, Jaffray DA, Martinez AA, Wong JW: Active breathing control (ABC) for Hodgkin's disease: reduction in normal tissue irradiation with deep inspiration and implications for treatment. Intern J Rad Oncol Biol Phys 2000;48:797-806.
45. Jules-Elysee K, White DA: Bleomycin-induced pulmonary toxicity. Clin Chest Med 1990;11:1-20.
46. Gharaee-Kermani, Ullenbruch M, Phan SH: Animal models of pulmonary fibrosis. Meth Mol Med 2005;117:251-9.
47. Martin WG, Ristow KM, Habermann TM, Colgan JP, Witzig TE, Ansell SM: Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma. J Clin Oncol 2005;23:7614-20.
48. Canellos GP, Anderson JR, Propert KJ, Nissen N, Cooper MR, Henderson ES, Green MR, Gottlieb A, Paterson BA: Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. New Engl J Med 1992;327:1478-84.
49. Hirsch A, Vander Els NV, Straus DJ, Gomez EG, Leung D, Portlock CS, Yahalom J: Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin's disease. J Clin Oncol 1996;14:1297-305.
50. Aisenberg AC: Problems in Hodgkin's disease management. Blood 1999;93:761-79.
51. Balikian JP, Jochelson MS, Bauer KA, Skarkin AT, Garnick MB, Canellos GP, Smith EH: Pulmonary complications of chemotherapy regimens containing bleomycin. Am J Roentg 1982;139:445-61.
52. Santrach PJ, Askin FB, Wells RJ, Azizkhan RG, Merten DF: Nodular form of bleomycin-related pulmonary injury in patients with osteogenic sarcoma. Cancer 1989;64:806-11.
53. White DA, Stover DE: Severe bleomycin-induced pneumonitis. Clinical features and response to corticosteroids. Chest 1984;86:723-8.
54. Karakantza M, Matutes E, MacLennan K, O'Connor NTJ, Srivastava PC, Catovsky D: Association between sarcoidosis and lymphoma revisited. J Clin Pathol 1996;49:208-12.
55. Trier H, Christensen M: Hodgkin's disease in sarcoidosis. A case report and a review of the literature. Acta Med Scand 1985;218:137-40.
56. Daly PA, O'Briain DS, Robinson I, Guckian M, Prichard JS: Hodgkin's disease with a granulomatous pulmonary presentation mimicking sarcoidosis. Thorax 1988;43:407-9.
57. Merchant TE, Filippa DA, Yahalom J: Sarcoidosis following chemotherapy for Hodgkin's disease. Leuk Lymph 1994;13:339-47.
58. Van den Berg, Fickers M, Theunissen P, Van Noord JA: Pulmonary sarcoid-like granuloma in a patient treated for extrapulmonary Hodgkin's disease. Respiration 1997;64:114-7.
59. De Hemricourt E, De Boeck K, Hilte F, Abib A, Kockx M, Vandevivere J, De Bock R: Sarcoidosis and sarcoid-like reaction following Hodgkin's disease. Report of two cases. Mol Im Biol 2003;5:15-9.
60. Sajjad SM, Luna MA: Primary pulmonary histiocytosis X in two patients with Hodgkin's disease. Thorax 1982;37:110-3.
61. Shanley DJ, Lerud KS et Luetkehans TJ: Development of pulmonary histiocytosis X after chemotherapy for Hodgkin disease. AJR 1990;155:741-2.
62. Unger JM, England DM et Collins J: Miliary nodules, Hodgkin's disease, and eosinophilic granuloma. J Thor Imag 1994;9:71-3.
63. L'Hoste RJ, Arrowsmith WR, Leonard GL et McGaw H: Eosinophilic granuloma occurring in a patient with Hodgkin disease. Human Pathology 1982;13:592-5.
64. Burns BF, Colby TV et Dorfman RF: Langerhans' cell granulomatosis (histiocytosis X) associated with malignant lymphomas. Am J Surg Pathol 1983;7:529-33.
65. Pezner RD, Horak DA, Sayegh HO et Lipsett JA: Spontaneous pneumothorax in patients irradiated for Hodgkin's disease and other malignant lymphomas. Int J Rad Oncol Biol Phys 1990;18:193-8.
66. Dores GM, Metayer C, Curtis RE, Lynch CF, Clarke EA, Glimelius B, Storm H, Pukkala E, van Leeuwen FE, Holowaty EJ, Andersson M, Wiklund T, Joensuu T, van't Veer MB, Stovall M, Gospodarowicz M, Travis LB: Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol 2002;20:3484-94.
67. Swerdlow AJ, Barber JA, Hudson GV, Cunningham D, Gupta RK, Hancock BW, Horwich A, Lister TA, Linch DC: Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol 2000;18:498-509.
68. Ng AK, Bernardo MVP, Weller E, Backstrand K, Silver B, Marcus KC, Tarbell NJ, Stevenson MA, Friedberg JW, Mauch PM: Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood 2002;100:1989-96.
69. Van Leeuwen FE, Klokman WJ, Van't Veer MB, Hagenbeek A, Krol AD, Vetter KA, Schaapveld M, van Heerde P, Burgers JM, Somers R, Aleman BM: Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adult. J Clin Oncol 2000;18:487-97.
70. Metayer C, Lynch CF, Clarke EA, Glimelius B, Storm H, Pukkala E, Joensuu T, van Leeuwen FE, van't Veer MB, Curtis RE, Holowaty EJ, Andersson M, Wiklund T, Gospodarowicz M, Travis LB: Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 2000;18:2435-43.
71. Bhatia S, Robison LL, Oberlin O, Greenberg M, Bunin G, Fosseti-Bellanin F, Meadows AT: Breast cancer and other malignant neoplasms after childhood Hodgkin's disease. New Engl J Med 1996;21;745-51.
72. Lorigan P, Radford J, Howell A, Thatcher N: Lung cancer after treatment for Hodgkin's lymphoma: a systematic review. Lancet Oncol 2005;6:773-9.
73. Laurie S, Kris M, Portlock C, Rosenzweig KE, Miller VA, Krug LM, Rusch VW: The clinical course of non-small cell lung cancer in survivors of Hodgkin's disease. Cancer 2002;95:119-26.